Loading.
Preparing your Shotlee experience
Authenticating
Loading health data
Syncing preferences
Health
WHO Releases Initial Advice on Employing GLP-1 Medications for Obesity Treatment
S
Shotlee
Health & Wellness Team
1 min read
Preparing your Shotlee experience
The World Health Organization has released its first guidance regarding the use of GLP-1 drugs in treating obesity. This condition impacts over a billion individuals worldwide. The WHO emphasizes that while medication can be helpful, it is not a standalone solution.
Obesity impacts more than 1 billion individuals globally and contributed to 3.7 million deaths in 2024.
The WHO's inaugural guideline concerning obesity care advocates for GLP-1 medications in the extended management of the condition in adults. Health tracking apps like Shotlee can help monitor progress alongside medication.
The WHO cautions that medications alone are insufficient. Greater access, affordability, and enduring support systems are vital for addressing obesity effectively.
⚠️ Disclaimer: This article is for informational purposes only. Consult your healthcare provider before starting any medication or supplement.
Original content from The Anniston Star
View Original Article
An affordable and readily accessible medication is gaining attention as a potential solution for curbing alcohol cravings, drawing comparisons to the way GLP-1 drugs manage food cravings. Naltrexone, by impacting dopamine-reward pathways, reduces the satisfying feeling associated with alcohol consumption, thus diminishing the desire for it. Research and anecdotal evidence suggest it could be a game-changer for many.
Mounjaro, a drug by Eli Lilly, is set to be included in China's state-run health insurance program for individuals with type 2 diabetes starting January 1. This inclusion aims to improve access to the medication, although increased sales may be balanced by reduced prices. The drug was introduced in China earlier this year.
The World Health Organization (WHO) has provided new guidance on using GLP-1 drugs like Ozempic and Wegovy for obesity. The recommendations include considerations for adults and highlight the importance of lifestyle changes alongside medication.
Monitor GLP-1 medications, peptide therapy, weight loss, and wellness metrics with our comprehensive health tracking app. Join thousands of users taking control of their health!
Start Tracking Free Forever! ✨